Overview of Course
At the end of this activity, CRNAs will maintain vigilance for RNMB in all their patients, use subjective PNS monitoring of the ulmar nerve or objective monitoring (if available) to monitor NMB, incorporate NMB reversal agents according to the current evidence, and collaborate with other team members to promote safe, patient-centered care (based on the AANA policy statement).
Supported by an education grant provided by Merck & Co., Inc.
Upon completion of this course, the learner will be able to:
Verification of Participation
The participant will have only 2 opportunities to successfully complete the course post-test, which is comprised of 5 random questions pulled from the test pool of questions. The passing score of at least 80% is required for the exam in this course. If the participant fails the post test, he or she will not receive CE credits for this course.
This course has been prior approved by the AANA for 1.0 Class A CE credit; AANA Code Number: 1036756.
Course Expiration Date: 1/30/2020
The American Association of Nurse Anesthetists is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.